ARTICLE | Clinical News
Biomarker Panels diagnostic data
January 5, 2009 8:00 AM UTC
Data from 115 evaluable patients with triple negative breast cancers enrolled in a U.S. trial showed that a panel of 4 DNA repair proteins (XPF, FANCD2, MLH1 and MK2) met the primary endpoint of pr...